The Opto⢠Cell Line Development 2.0 workflow, designed for the Beacon® optofluidic instrument, generates in just days the best production cell lines for complex antibody therapeutics with more than 99% monoclonality assurance.
Image Credit: utas7777777/Shutt⦠[+3252 chars]Source
